
SINGAPORE,Feb. 21,2025 -- HIX.AI has been a trusted name in the AI world,originally specializing in advanced AI search capabilities. Now,it has taken a bold step forward by becoming an unlimited free AI chat platform for the revolutionary DeepSeek R1 model.
DeepSeek R1,developed by a Chinese startup,has been described as a disruptive force in the AI industry,rivaling leading models like GPT-4o while being significantly more cost-effective. Now HIX.AI is making this groundbreaking model completely free and unlimited for all users. This means they can interact with DeepSeek without worrying about restrictions on usage,downtime,or subscription fees.
But DeepSeek R1 is just one of the many models available on the new and repurposed HIX.AI. It also offers users access to many other leading AI chat models,including ChatGPT,GPT-4o,Claude,Gemini,and more. You can switch between them on the fly and chat with numerous large language models at the same time.
This opens a lot of potential uses and opportunities for HIX.AI users. They can use the many chatbots provided to tackle complex tasks from multiple angles,research topics,get help on their coding projects and other professional endeavors,or just chat about almost any subject on their mind. The uses are nearly limitless.
In brief,HIX.AI now aims to be every user's go-to platform for instant,free,and unlimited AI chat for DeepSeek. It also gives you full and complete access to so many AI chat tools,you'll never need to go anywhere else. It's easy to work with,suiting both beginner and experienced users alike,and it's great for both personal and professional use.
For more information about the revamped HIX.AI and to experience the disruptive potential of DeepSeek at no cost and with no limits,visit https://hix.ai.
MEDIA CONTACT
Camille Sawyer
CEO,HIX.AI
support@hix.ai
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map